Darpaz Interactions
There are 754 drugs known to interact with Darpaz (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate), along with 37 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 256 are major, 483 are moderate, and 15 are minor.
- View all 754 medications that may interact with Darpaz
- View Darpaz alcohol/food interactions (3)
- View Darpaz disease interactions (37)
Most frequently checked interactions
View interaction reports for Darpaz (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate) and the medicines listed below.
- aloe vera
- Atarax (hydroxyzine)
- Benadryl (diphenhydramine)
- betaine
- chromium picolinate
- clonazepam
- Diflucan (fluconazole)
- Digipepsin (pancreatin)
- Ditropan XL (oxybutynin)
- Exalgo (hydromorphone)
- Ginger Root (ginger)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- hydrochlorothiazide
- Levsin (hyoscyamine)
- lorazepam
- Omega 3-6-9 Complex (omega-3 polyunsaturated fatty acids)
- Pancreatin 4X (pancreatin)
- papaya
- peppermint
- pineapple
- promethazine
- Prozac (fluoxetine)
- Pyridium Plus (butabarbital / hyoscyamine / phenazopyridine)
- Roxicodone (oxycodone)
- royal jelly
- Soma (carisoprodol)
- Vitamin A, D (multivitamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zovirax (acyclovir)
Darpaz alcohol/food interactions
There are 3 alcohol/food interactions with Darpaz (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate).
Darpaz disease interactions
There are 37 disease interactions with Darpaz (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate) which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- inflammatory bowel disease
- intestinal obstruction disorders
- crystalluria
- gout
- liver disease
- methemoglobinemia in G-6-PD
- hypocalcemia
- phosphate imbalance
- GI toxicity
- renal dysfunction
- Reye's syndrome
- electrolyte imbalance
- cardiac disease
- tachycardia
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- liver disease
- renal failure
- renal dysfunction
- anemia
- coagulation
- dialysis
- G-6-PD deficiency
- hepatotoxicity
- hypertension
- hyperthyroidism
- diarrhea
- fever
More about Darpaz (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.